Skip to main content
. 2019 Mar 30;11(4):458. doi: 10.3390/cancers11040458

Figure 3.

Figure 3

ctDNA analysis of KRAS-mutated metastatic cancer patients (8) per centrifugation protocol (Table 1) in EDTA (left) and Streck (right) tubes. (A) Concentration of KRAS-mutated ctDNA (copies/mL); (B) KRAS-mutated ctDNA allele frequency (%); N: number of participants.